| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |